Works by Abada, Paolo

Results: 22
    1
    2

    Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).

    Published in:
    Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 451, doi. 10.1159/000516605
    By:
    • Kudo, Masatoshi;
    • Finn, Richard S.;
    • Morimoto, Manabu;
    • Rau, Kun-Ming;
    • Ikeda, Masafumi;
    • Yen, Chia-Jui;
    • Galle, Peter R.;
    • Llovet, Josep M.;
    • Daniele, Bruno;
    • Lim, Ho Yeong;
    • McIlwain, David W.;
    • Yoshikawa, Reigetsu;
    • Nakamura, Kenichi;
    • Liang, Kun;
    • Wang, Chunxiao;
    • Abada, Paolo;
    • Widau, Ryan C.;
    • Zhu, Andrew X.
    Publication type:
    Article
    3

    Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).

    Published in:
    Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 451, doi. 10.1159/000516605
    By:
    • Kudo, Masatoshi;
    • Finn, Richard S.;
    • Morimoto, Manabu;
    • Rau, Kun-Ming;
    • Ikeda, Masafumi;
    • Yen, Chia-Jui;
    • Galle, Peter R.;
    • Llovet, Josep M.;
    • Daniele, Bruno;
    • Lim, Ho Yeong;
    • McIlwain, David W.;
    • Yoshikawa, Reigetsu;
    • Nakamura, Kenichi;
    • Liang, Kun;
    • Wang, Chunxiao;
    • Abada, Paolo;
    • Widau, Ryan C.;
    • Zhu, Andrew X.
    Publication type:
    Article
    4
    5

    Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.

    Published in:
    2018
    By:
    • Chau, Ian;
    • Park, Joon Oh;
    • Ryoo, Baek-Yeol;
    • Yen, Chia-Jui;
    • Poon, Ronnie;
    • Pastorelli, Davide;
    • Blanc, Jean-Frédéric;
    • Kudo, Masatoshi;
    • Pfiffer, Tulio;
    • Hatano, Etsuro;
    • Chung, Hyun Cheol;
    • Kopeckova, Katerina;
    • Phelip, Jean-Marc;
    • Brandi, Giovanni;
    • Ohkawa, Shinichi;
    • Li, Chung-Pin;
    • Okusaka, Takuji;
    • Hsu, Yanzhi;
    • Abada, Paolo B.;
    • Zhu, Andrew X.
    Publication type:
    journal article
    6
    7
    8
    9

    S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY.

    Published in:
    2023
    By:
    • Brown, Jennifer R.;
    • Desikan, Sai Prasad;
    • Nguyen, Bastien;
    • Won, Helen;
    • Tantawy, Shady;
    • Mcneely, Samuel Clark;
    • Marella, Narasimha;
    • Ebata, Kevin;
    • Woyach, Jennifer;
    • Patel, Krish;
    • Tam, Constantine;
    • Eyre, Toby;
    • Cheah, Chan;
    • Shah, Nirav N;
    • Ghia, Paolo;
    • Jurczak, Wojciech;
    • Balbas, Minna;
    • Nair, Binoj;
    • Abada, Paolo;
    • Wang, Chunxiao
    Publication type:
    Abstract
    10

    Clinical outcomes among patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who received treatment with a covalent BTK and BCL2 inhibitor in the United States: a real-world database study.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 5, p. 1005, doi. 10.1080/10428194.2023.2190436
    By:
    • Eyre, Toby A.;
    • Hess, Lisa M.;
    • Sugihara, Tomoko;
    • He, Dan;
    • Khanal, Manoj;
    • Pagel, John M.;
    • Walgren, Richard A.;
    • B. Abada, Paolo;
    • Konig, Heiko;
    • Roeker, Lindsey E.;
    • Mato, Anthony
    Publication type:
    Article
    11
    12

    Clinical development and evaluation of a VEGF-D assay in plasma from patients with metastatic colorectal cancer in the RAISE study.

    Published in:
    Current Medical Research & Opinion, 2021, v. 37, n. 10, p. 1769, doi. 10.1080/03007995.2021.1940908
    By:
    • Taniguchi, Hiroya;
    • Yoshino, Takayuki;
    • Yamaguchi, Kensei;
    • Yamazaki, Kentaro;
    • Nixon, Andrew B.;
    • Tabernero, Josep;
    • Van Cutsem, Eric;
    • Robling, Kim R.;
    • Abada, Paolo B.;
    • Hozak, Rebecca R.;
    • Siegel, Robert;
    • Fill, Jeffrey A.;
    • Wijayawardana, Sameera;
    • Walgren, Richard A.;
    • Giles, Brendan;
    • Jones, Abby;
    • Pitts, Kelly R.;
    • Drove, Nora;
    • Muro, Kei
    Publication type:
    Article
    13
    14

    Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology.

    Published in:
    Liver International, 2021, v. 41, n. 11, p. 2759, doi. 10.1111/liv.14994
    By:
    • Galle, Peter R.;
    • Kudo, Masatoshi;
    • Llovet, Josep M.;
    • Finn, Richard S.;
    • Karwal, Mark;
    • Pezet, Denis;
    • Kim, Tae‐You;
    • Yang, Tsai‐Sheng;
    • Lonardi, Sara;
    • Tomasek, Jiri;
    • Phelip, Jean‐Marc;
    • Touchefeu, Yann;
    • Koh, Su‐Jin;
    • Stirnimann, Guido;
    • Liang, Kun;
    • Ogburn, Kenyon D.;
    • Wang, Chunxiao;
    • Abada, Paolo;
    • Widau, Ryan C.;
    • Zhu, Andrew X.
    Publication type:
    Article
    15
    16

    Issue Cover.

    Published in:
    Liver International, 2019, v. 39, n. 12, p. i, doi. 10.1111/liv.14277
    By:
    • Galle, Peter R.;
    • Foerster, Friedrich;
    • Kudo, Masatoshi;
    • Chan, Stephen L.;
    • Llovet, Josep M.;
    • Qin, Shukui;
    • Schelman, William R.;
    • Chintharlapalli, Sudhakar;
    • Abada, Paolo B.;
    • Sherman, Morris;
    • Zhu, Andrew X.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22